Mario Gabelli Chroma Dex Corp. Transaction History
Gamco Investors, Inc. Et Al
- $8.37 Billion
- Q1 2025
A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Chroma Dex Corp. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 142,800 shares of CDXC stock, worth $876,792. This represents 0.01% of its overall portfolio holdings.
Number of Shares
142,800
Previous 141,000
1.28%
Holding current value
$876,792
Previous $748,000
31.68%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding CDXC
# of Institutions
149Shares Held
24.4MCall Options Held
190KPut Options Held
14.1K-
Vanguard Group Inc Valley Forge, PA3.54MShares$21.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$19.1 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA1.99MShares$12.2 Million6.26% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.28MShares$7.88 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.18MShares$7.24 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $420M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...